Soros Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Soros Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,619	Closed	-$1.78M	–	63
2026 Q1	$1.78M	Sell	3,619 -804	-18%	-$436K	0.77%	36
2025 Q4	$2.56M	Buy	4,423 +778	+21%	+$440K	0.67%	40
2025 Q3	$1.77M	Sell	3,645 -330	-8%	-$154K	0.44%	47
2025 Q2	$1.61M	Buy	+3,975	New	+$1.66M	0.46%	41

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Soros Capital Management's TMO Position: Q2 2026 in Review

Soros Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,619 shares — an estimated $1.78M sold.

Soros Capital Management first reported a position in TMO in Q2 2025 and held it in 4 quarters. The position peaked at $2.56M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Soros Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Soros Capital Management sold 3,619 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.78M.
Soros Capital Management first reported a position in Thermo Fisher Scientific in Q2 2025 and held it in 4 quarters.
Soros Capital Management's Thermo Fisher Scientific position peaked at $2.56M in Q4 2025.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Soros Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.